Calliditas Spies Chinese Market As Tarpeyo Continues Upwards Sales Curve
IgAN Therapy Advancing In US
The Swedish biotech’s successful launch in the US of Tarpeyo for immunoglobulin A nephropathy is progressing well and a Chinese approval is on the horizon as partner Everest’s application is accepted by regulators.
